Kerala Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
- Paid Up Capital ₹ 12.03 Cr
- Company Age 32 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.40 Cr
- Satisfied Charges ₹ 74.75 Cr
- Revenue Growth 29.35%
- Profit Growth 117.97%
- Ebitda 6492.84%
- Net Worth 12.29%
- Total Assets -4.71%
About Kerala Ayurveda
Kerala Ayurveda Limited (KAL) is a leading Public Limited Indian Non-Government Company incorporated in India on 06 July 1992 and has a history of 32 years and six months. Its registered office is in Ernakulam, Kerala, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530163.
The Corporate was formerly known as Pensum Ayurveda Pharmaceuticals Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 12.03 Cr.
The company currently has active open charges totaling ₹18.40 Cr. The company has closed loans amounting to ₹74.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kerala Ayurveda Limited India are Vivek Sunder as Ceo, Thomas George as Cfo, and Jyothikumari as Company Secretary. Ramesh Vangal, Anand Subramanian, Kunjupanicker Anilkumar, and Five other members serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24233KL1992PLC006592
- Company No.
006592
- Stock Symbol
BSE : 530163
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Jul 1992
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ernakulam
Industry
What products or services does Kerala Ayurveda Limited offer?
Kerala Ayurveda Limited offers a wide range of products and services, including Health Club Services, Meditation Center, Tour Packages, Ayurveda Health Tourism, Hotel Bookings, Resort Rental Services, Health Conditions, Stomach Care.
Who are the key members and board of directors at Kerala Ayurveda?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Sunder | CEO | 01-Nov-2023 | Current |
| Thomas George | CFO | 28-Jun-2022 | Current |
| Jyothikumari | Company Secretary | 14-Feb-2023 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shilpa Gududur  | Director | 15-Feb-2021 | Current |
Ramesh Vangal  | Director | 02-Sep-2006 | Current |
| Anand Subramanian | Director | 11-Oct-2010 | Current |
| Kunjupanicker Anilkumar | Whole-Time Director | 28-Jun-2006 | Current |
| Rajesh Sharma | Director | 28-Jun-2022 | Current |
| Samir Dhawan | Additional Director | 04-Oct-2024 | Current |
Financial Performance of Kerala Ayurveda.
Kerala Ayurveda Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.35% increase. The company also saw a substantial improvement in profitability, with a 117.97% increase in profit. The company's net worth Soared by an impressive increase of 12.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kerala Ayurveda?
In 2022, Kerala Ayurveda had a promoter holding of 61.52% and a public holding of 38.49%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Katra Wilhelmsen Logistics Private LimitedAnand Subramanian is a mutual person
Katra Holding Private LimitedRamesh Vangal and Anand Subramanian are mutual person
Katra Phytochem (India) Private LimitedRamesh Vangal and Anand Subramanian are mutual person
Planet Herbs Lifesciences Private LimitedSamir Dhawan is a mutual person
Tressmart Marketing Private LimitedSamir Dhawan is a mutual person
Arna Medisciences Private LimitedSamir Dhawan is a mutual person
Charges (Loans)
₹18.40 Cr
₹74.75 Cr
Charges Breakdown by Lending Institutions
- Others : 18.35 Cr
- State Bank Of India : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Mar 2023 | Others | ₹18.35 Cr | Open |
| 31 Mar 2021 | State Bank Of India | ₹0.45 M | Open |
| 25 Aug 2020 | Others | ₹7.50 M | Satisfied |
| 06 Feb 2018 | Others | ₹30.00 Cr | Satisfied |
| 08 Jun 2017 | Others | ₹17.00 Cr | Satisfied |
How Many Employees Work at Kerala Ayurveda?
Kerala Ayurveda has a workforce of 334 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kerala Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kerala Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
